Department of Medicine

October 5, 2023

Jane Case named associate vice chair for Advanced Practice for the Department of Medicine

Jane Case, DNP, APRN-BC, has been named associate vice chair for Advanced Practice for the Department of Medicine at Vanderbilt University Medical Center.

By Matt Batcheldor
The study team included, from left, Paula Gonzalez-Ericsson, MD, Xiaopeng Sun, Justin Balko, PharmD, PhD, and Brandie Taylor, MS. (photo by Donn Jones)
October 4, 2023

Vulnerability found in immunotherapy-resistant triple-negative breast cancer

Vanderbilt researchers have discovered a druggable target on natural killer cells that could potentially trigger a therapeutic response in patients with immunotherapy-resistant, triple-negative breast cancer.

By Tom Wilemon
October 3, 2023

Levi Watkins Jr., MD Lecture set for Oct. 24

The 22nd annual Levi Watkins Jr., MD Lecture will be held Tuesday, Oct. 24, at noon in 208 Light Hall.

By VUMC News and Communications
VUMC’s new automated biobanking system can store as many as 10 million biospecimens.
October 3, 2023

Research fellowship for genetic counselors established at Vanderbilt

Vanderbilt University School of Medicine has received a grant to establish a research fellowship for genetic counselors that will prepare them to contribute more fully to the advancement of personalized medicine.

By Bill Snyder
Sharon Kantanie, center, participated in the study of a drug that reduced soft-tissue flare-ups and the prevented new areas of abnormal bone formation. With her are, from left, Emily Shardelow, clinical/translational research coordinator; Sharon’s parents, Mary and Stan Kantanie; Margo Black, MSN, manager of research projects for Metabolic Bone Disorders; and Kathryn Dahir, MD, professor of Endocrinology and Diabetes. (photo by Erin O. Smith)
September 28, 2023

Drug trial shows reduced abnormal bone formation in those with fibrodysplasia ossificans progressiva

A Vanderbilt clinical trial evaluating the investigational drug garetosmab has shown that it reduced soft-tissue flare-ups significantly and prevented new areas of abnormal bone formation in patients with fibrodysplasia ossificans progressiva.

By Jill Clendening
Frank Mason, PhD, left, Kimryn Rathmell, MD, PhD, and their colleagues have identified an early event in the development of cancer, one that could lead to new ways to prevent it. (photo by Erin O. Smith)
September 20, 2023

VUMC study reveals critical first steps to cancer

A new study by Vanderbilt researchers provides a remarkably detailed view of the earliest events leading to the development of cancer, and of potential new ways to prevent it.

By Bill Snyder
September 19, 2023

$51 million NIH grant brings ELVIS to VUMC

Vanderbilt University Medical Center scientists are launching a research platform called ELVIS that is devoted to molecular underpinnings of early-childhood determinants of health.
By Paul Govern
September 12, 2023

Takkouche named associate chief medical officer for Wilson and Sumner County regions

Sahar Takkouche, MD, director of the Vanderbilt Weight Loss Center in Wilson County, has been named to the role of associate chief medical officer for Wilson and Sumner County regions.
By VUMC News and Communications
August 30, 2023

Music therapy program now offered to patients on three additional units at VUH

Following a successful pilot program, music therapy is now being offered to patients on three additional units at Vanderbilt University Hospital.
By Jessica Pasley
August 10, 2023

New leaders named to Vanderbilt-Ingram research programs

Seven new leaders have been appointed to guide Vanderbilt-Ingram Cancer Center’s research programs.
By Tom Wilemon
August 10, 2023

Messaging changes benefit both providers and patients

Vanderbilt University Medical Center has just rolled out changes to streamline and better manage messaging between patients and their care providers.
By Jill Clendening
August 9, 2023

VUMC receives $51 million in NIH grants to improve efficiency of conducting clinical trials across the US

Vanderbilt researchers have been awarded two five-year federal grants totaling $51 million to harness new and existing approaches for boosting recruitment and removing roadblocks to the efficiency of conducting clinical trials throughout the country.
By Bill Snyder
August 8, 2023

Chronic complications from immunotherapies more prevalent and persistent than previously shown among melanoma survivors

A Vanderbilt study has found that chronic immunotherapy-related complications are more prevalent and persistent than previously shown among melanoma survivors.
By Tom Wilemon
1 … 6 7 8 9 10 … 96